Saroglitazar for the Treatment of NASH: The Peroxisome Proliferator-Activated Receptor Story Goes On! Francque S. Hepatology 2021;74:1730-1733.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Francque S. Saroglitazar for the Treatment of NASH: The Peroxisome Proliferator-Activated Receptor Story Goes On! Hepatology 2021;74:1730-1733.
PMID: 34161617